Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 303

1.

GSTM1 copy number and promoter haplotype as predictors for risk of recurrence and/or second primary tumor in patients with head and neck cancer.

Zhang X, Huang M, Wu X, Kadlubar S, Lin J, Yu X, Fan C, Ning B, Kadlubar FF.

Pharmgenomics Pers Med. 2013;6:9-17. doi: 10.2147/PGPM.S35949. Epub 2013 Mar 1.

2.

Association between GSTM1 copy number, promoter variants and susceptibility to urinary bladder cancer.

Zhang X, Lin J, Wu X, Lin Z, Ning B, Kadlubar S, Kadlubar FF.

Int J Mol Epidemiol Genet. 2012;3(3):228-36. Epub 2012 Aug 31.

3.

Sequence variants in antioxidant defense and DNA repair genes, dietary antioxidants, and pancreatic cancer risk.

Zhang J, Zhang X, Dhakal IB, Gross MD, Kadlubar FF, Anderson KE.

Int J Mol Epidemiol Genet. 2011 Aug 30;2(3):236-44. Epub 2011 Jun 5.

4.

Ultraperformance liquid chromatography-tandem mass spectrometry method for biomonitoring cooked meat carcinogens and their metabolites in human urine.

Gu D, Raymundo MM, Kadlubar FF, Turesky RJ.

Anal Chem. 2011 Feb 1;83(3):1093-101. doi: 10.1021/ac102918b. Epub 2010 Dec 31.

5.

Functional genetic variants in the 3'-untranslated region of sulfotransferase isoform 1A1 (SULT1A1) and their effect on enzymatic activity.

Yu X, Dhakal IB, Beggs M, Edavana VK, Williams S, Zhang X, Mercer K, Ning B, Lang NP, Kadlubar FF, Kadlubar S.

Toxicol Sci. 2010 Dec;118(2):391-403. doi: 10.1093/toxsci/kfq296. Epub 2010 Sep 29.

6.

Identification of carcinogen DNA adducts in human saliva by linear quadrupole ion trap/multistage tandem mass spectrometry.

Bessette EE, Spivack SD, Goodenough AK, Wang T, Pinto S, Kadlubar FF, Turesky RJ.

Chem Res Toxicol. 2010 Jul 19;23(7):1234-44. doi: 10.1021/tx100098f.

7.

Polymorphisms in inflammatory genes, plasma antioxidants, and prostate cancer risk.

Zhang J, Dhakal IB, Lang NP, Kadlubar FF.

Cancer Causes Control. 2010 Sep;21(9):1437-44. doi: 10.1007/s10552-010-9571-0. Epub 2010 Apr 30.

8.

A comprehensive approach to the profiling of the cooked meat carcinogens 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, and their metabolites in human urine.

Gu D, McNaughton L, Lemaster D, Lake BG, Gooderham NJ, Kadlubar FF, Turesky RJ.

Chem Res Toxicol. 2010 Apr 19;23(4):788-801. doi: 10.1021/tx900436m.

9.

Expression of sulfotransferase isoform 1A1 (SULT1A1) in breast cancer cells significantly increases 4-hydroxytamoxifen-induced apoptosis.

Mercer KE, Apostolov EO, Gamboa da Costa G, Yu X, Lang P, Roberts DW, Davis W, Basnakian AG, Kadlubar FF, Kadlubar SA.

Int J Mol Epidemiol Genet. 2010 Jan 30;1(2):92-103.

10.

Polymorphisms in hOGG1 and XRCC1 and risk of prostate cancer: effects modified by plasma antioxidants.

Zhang J, Dhakal IB, Greene G, Lang NP, Kadlubar FF.

Urology. 2010 Apr;75(4):779-85. doi: 10.1016/j.urology.2009.08.063. Epub 2009 Nov 14.

11.

Physical activity, diet, and pancreatic cancer: a population-based, case-control study in Minnesota.

Zhang J, Dhakal IB, Gross MD, Lang NP, Kadlubar FF, Harnack LJ, Anderson KE.

Nutr Cancer. 2009;61(4):457-65. doi: 10.1080/01635580902718941.

12.

Phenotypic CYP2A6 variation and the risk of pancreatic cancer.

Kadlubar S, Anderson JP, Sweeney C, Gross MD, Lang NP, Kadlubar FF, Anderson KE.

JOP. 2009 May 18;10(3):263-70.

13.

Sulfotransferase 4A1.

Minchin RF, Lewis A, Mitchell D, Kadlubar FF, McManus ME.

Int J Biochem Cell Biol. 2008;40(12):2686-91. doi: 10.1016/j.biocel.2007.11.010. Epub 2007 Dec 3. Review.

PMID:
18248844
14.

Increased distributional variance of mitochondrial DNA content associated with prostate cancer cells as compared with normal prostate cells.

Mizumachi T, Muskhelishvili L, Naito A, Furusawa J, Fan CY, Siegel ER, Kadlubar FF, Kumar U, Higuchi M.

Prostate. 2008 Mar 1;68(4):408-17. doi: 10.1002/pros.20697.

15.

The UGT2B17 gene deletion polymorphism and risk of prostate cancer. A case-control study in Caucasians.

Gallagher CJ, Kadlubar FF, Muscat JE, Ambrosone CB, Lang NP, Lazarus P.

Cancer Detect Prev. 2007;31(4):310-5.

16.

Plasma carotenoids and prostate cancer: a population-based case-control study in Arkansas.

Zhang J, Dhakal I, Stone A, Ning B, Greene G, Lang NP, Kadlubar FF.

Nutr Cancer. 2007;59(1):46-53.

PMID:
17927501
17.

Cystine-glutamate transporter SLC7A11 mediates resistance to geldanamycin but not to 17-(allylamino)-17-demethoxygeldanamycin.

Liu R, Blower PE, Pham AN, Fang J, Dai Z, Wise C, Green B, Teitel CH, Ning B, Ling W, Lyn-Cook BD, Kadlubar FF, Sadée W, Huang Y.

Mol Pharmacol. 2007 Dec;72(6):1637-46. Epub 2007 Sep 17.

18.

Hormone-metabolizing genotypes: an alternate interpretation.

Kadlubar FF.

Cancer Epidemiol Biomarkers Prev. 2007 Sep;16(9):1911. No abstract available.

19.

A variant of the Cockayne syndrome B gene ERCC6 confers risk of lung cancer.

Lin Z, Zhang X, Tuo J, Guo Y, Green B, Chan CC, Tan W, Huang Y, Ling W, Kadlubar FF, Lin D, Ning B.

Hum Mutat. 2008 Jan;29(1):113-22.

20.

Hair dye use, meat intake, and tobacco exposure and presence of carcinogen-DNA adducts in exfoliated breast ductal epithelial cells.

Ambrosone CB, Abrams SM, Gorlewska-Roberts K, Kadlubar FF.

Arch Biochem Biophys. 2007 Aug 15;464(2):169-75. Epub 2007 Jun 8.

PMID:
17601487
21.

Reply to the letter to the Editor: "N-Acetyltransferases and the susceptibility to benzidine-induced bladder carcinogenesis".

Carreón T, Kadlubar FF, Ruder AM, Schulte PA, Hayes RB, Waters M, Grant DJ, Boissy R, Bell DA, Hemstreet GP 3rd, Yin S, Lemasters GK, Rothman N.

Int J Cancer. 2007 Oct 1;121(7):1637-9; author reply 1640-1. No abstract available.

22.
23.

Processed meat intake, CYP2A6 activity and risk of colorectal adenoma.

Ward MH, Cross AJ, Divan H, Kulldorff M, Nowell-Kadlubar S, Kadlubar FF, Sinha R.

Carcinogenesis. 2007 Jun;28(6):1210-6. Epub 2007 Feb 2.

PMID:
17277235
24.

CYP2A13 expressed in human bladder metabolically activates 4-aminobiphenyl.

Nakajima M, Itoh M, Sakai H, Fukami T, Katoh M, Yamazaki H, Kadlubar FF, Imaoka S, Funae Y, Yokoi T.

Int J Cancer. 2006 Dec 1;119(11):2520-6.

25.

Deletion polymorphism of UDP-glucuronosyltransferase 2B17 and risk of prostate cancer in African American and Caucasian men.

Park J, Chen L, Ratnashinge L, Sellers TA, Tanner JP, Lee JH, Dossett N, Lang N, Kadlubar FF, Ambrosone CB, Zachariah B, Heysek RV, Patterson S, Pow-Sang J.

Cancer Epidemiol Biomarkers Prev. 2006 Aug;15(8):1473-8.

26.

Associations between catalase phenotype and genotype: modification by epidemiologic factors.

Ahn J, Nowell S, McCann SE, Yu J, Carter L, Lang NP, Kadlubar FF, Ratnasinghe LD, Ambrosone CB.

Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1217-22.

27.

Synergic effect of polymorphisms in ERCC6 5' flanking region and complement factor H on age-related macular degeneration predisposition.

Tuo J, Ning B, Bojanowski CM, Lin ZN, Ross RJ, Reed GF, Shen D, Jiao X, Zhou M, Chew EY, Kadlubar FF, Chan CC.

Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9256-61. Epub 2006 Jun 5.

28.

Search for an association between the human CYP1A2 genotype and CYP1A2 metabolic phenotype.

Jiang Z, Dragin N, Jorge-Nebert LF, Martin MV, Guengerich FP, Aklillu E, Ingelman-Sundberg M, Hammons GJ, Lyn-Cook BD, Kadlubar FF, Saldana SN, Sorter M, Vinks AA, Nassr N, von Richter O, Jin L, Nebert DW.

Pharmacogenet Genomics. 2006 May;16(5):359-67.

PMID:
16609368
29.
30.

Dietary intake of heterocyclic amines and benzo(a)pyrene: associations with pancreatic cancer.

Anderson KE, Kadlubar FF, Kulldorff M, Harnack L, Gross M, Lang NP, Barber C, Rothman N, Sinha R.

Cancer Epidemiol Biomarkers Prev. 2005 Sep;14(9):2261-5.

31.

Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer.

Zhang X, Miao X, Tan W, Ning B, Liu Z, Hong Y, Song W, Guo Y, Zhang X, Shen Y, Qiang B, Kadlubar FF, Lin D.

Gastroenterology. 2005 Aug;129(2):565-76.

PMID:
16083713
32.

A modified host cell reactivation assay to measure DNA repair capacity for removing 4-aminobiphenyl adducts: a pilot study of bladder cancer.

Lin J, Kadlubar FF, Spitz MR, Zhao H, Wu X.

Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1832-6.

33.

NAT2 slow acetylation and bladder cancer in workers exposed to benzidine.

Carreón T, Ruder AM, Schulte PA, Hayes RB, Rothman N, Waters M, Grant DJ, Boissy R, Bell DA, Kadlubar FF, Hemstreet GP 3rd, Yin S, LeMasters GK.

Int J Cancer. 2006 Jan 1;118(1):161-8.

34.

Common genetic polymorphisms in the 5'-flanking region of the SULT1A1 gene: haplotypes and their association with platelet enzymatic activity.

Ning B, Nowell S, Sweeney C, Ambrosone CB, Williams S, Miao X, Liang G, Lin D, Stone A, Ratnasinghe DL, Manjanatha M, Lang NP, Kadlubar FF.

Pharmacogenet Genomics. 2005 Jul;15(7):465-73.

PMID:
15970794
35.

Association of genetic variation in tamoxifen-metabolizing enzymes with overall survival and recurrence of disease in breast cancer patients.

Nowell SA, Ahn J, Rae JM, Scheys JO, Trovato A, Sweeney C, MacLeod SL, Kadlubar FF, Ambrosone CB.

Breast Cancer Res Treat. 2005 Jun;91(3):249-58.

36.

CYP3A43 Pro(340)Ala polymorphism and prostate cancer risk in African Americans and Caucasians.

Stone A, Ratnasinghe LD, Emerson GL, Modali R, Lehman T, Runnells G, Carroll A, Carter W, Barnhart S, Rasheed AA, Greene G, Johnson DE, Ambrosone CB, Kadlubar FF, Lang NP.

Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1257-61.

38.

Mitochondrial mutagenesis and oxidative stress in human prostate cancer.

Chen JZ, Kadlubar FF.

J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2004 May;22(1):1-12. Review.

PMID:
15845219
39.

Lactoperoxidase-catalyzed activation of carcinogenic aromatic and heterocyclic amines.

Gorlewska-Roberts KM, Teitel CH, Lay JO Jr, Roberts DW, Kadlubar FF.

Chem Res Toxicol. 2004 Dec;17(12):1659-66.

PMID:
15606142
40.

Sex differences in cytochrome P450 1B1, an estrogen-metabolizing enzyme, in the rhesus monkey telencephalon.

Scallet AC, Muskhelishvili L, Slikker W Jr, Kadlubar FF.

J Chem Neuroanat. 2005 Jan;29(1):71-80.

PMID:
15589702
41.

Examination of human tissue cytosols for expression of sulfotransferase isoform 1A2 (SULT1A2) using a SULT1A2-specific antibody.

Nowell S, Green B, Tang YM, Wiese R, Kadlubar FF.

Mol Pharmacol. 2005 Feb;67(2):394-9. Epub 2004 Nov 4.

42.

Potential chemoprotective effects of the coffee components kahweol and cafestol palmitates via modification of hepatic N-acetyltransferase and glutathione S-transferase activities.

Huber WW, Teitel CH, Coles BF, King RS, Wiese FW, Kaderlik KR, Casciano DA, Shaddock JG, Mulder GJ, Ilett KF, Kadlubar FF.

Environ Mol Mutagen. 2004;44(4):265-76.

PMID:
15468054
43.

SNPs, haplotypes, and cancer: applications in molecular epidemiology.

Rebbeck TR, Ambrosone CB, Bell DA, Chanock SJ, Hayes RB, Kadlubar FF, Thomas DC.

Cancer Epidemiol Biomarkers Prev. 2004 May;13(5):681-7. No abstract available.

44.

Lack of association between Caucasian lung cancer risk and O6-methylguanine-DNA methyltransferase-codon 178 genetic polymorphism.

Yang M, Coles BF, Caporaso NE, Choi Y, Lang NP, Kadlubar FF.

Lung Cancer. 2004 Jun;44(3):281-6.

PMID:
15140540
45.

Human glutathione S-transferase A2 polymorphisms: variant expression, distribution in prostate cancer cases/controls and a novel form.

Ning B, Wang C, Morel F, Nowell S, Ratnasinghe DL, Carter W, Kadlubar FF, Coles B.

Pharmacogenetics. 2004 Jan;14(1):35-44.

PMID:
15128049
46.

Formation and reduction of aryl and heterocyclic nitroso compounds and significance in the flux of hydroxylamines.

Kim D, Kadlubar FF, Teitel CH, Guengerich FP.

Chem Res Toxicol. 2004 Apr;17(4):529-36.

PMID:
15089095
47.

Association of SULT1A1 phenotype and genotype with prostate cancer risk in African-Americans and Caucasians.

Nowell S, Ratnasinghe DL, Ambrosone CB, Williams S, Teague-Ross T, Trimble L, Runnels G, Carrol A, Green B, Stone A, Johnson D, Greene G, Kadlubar FF, Lang NP.

Cancer Epidemiol Biomarkers Prev. 2004 Feb;13(2):270-6.

48.

Increased transcriptional activity of the CYP3A4*1B promoter variant.

Amirimani B, Ning B, Deitz AC, Weber BL, Kadlubar FF, Rebbeck TR.

Environ Mol Mutagen. 2003;42(4):299-305.

PMID:
14673875
49.

Identification of aminobiphenyl derivatives in commercial hair dyes.

Turesky RJ, Freeman JP, Holland RD, Nestorick DM, Miller DW, Ratnasinghe DL, Kadlubar FF.

Chem Res Toxicol. 2003 Sep;16(9):1162-73.

PMID:
12971805

Supplemental Content

Loading ...
Support Center